Cardiovascular Innovation Institute

Nonprofit profile at a glance

EIN
201319658
IRS 990 coverage
2011–2018
Official website data refreshed
Sep 2026
Forms available
Form 990 2018
Location
Louisville, KY, US
Phone
502-852-5511
Rating
71
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Judaism
Affiliation
Judaism

Official website

Reported finances

Revenue
$857,544
Expenses
$759,801
Assets
$0
Liabilities
$0

Source: IRS Form 990. Selected filing: tax year 2018. Amounts in USD.

Leadership & pay

13 people listed

Source: IRS Form 990. Selected filing: tax year 2018. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

To advance cardiovascular research and innovation through a partnership between the University of Louisville and Jewish Heritage Fund for Excellence.

What it reported doing in 2018

Research in the Cardiovascular Innovation Institute (CII) is focused on studying how the heart and cardiovascular system functions both normally and in the diseased state. The CII is doing research on the cellular and molecular level developing new knowledge on the underlining cause of cardiovascular disease. One of our researchers is studying small vessel disease in the hearts of women. This research is leading to new therapies for the treatment of women who have myocardial infarctions. Along with this research, work is being performed with adult stem cells turning the these cells into capillary to be vascularized ischemic myocardium. This work has been recognized by the National Institutes of Health and resulted in a R01 grant. Other researchers in the CII are working with C - RNA to detect both heart and lung disease and to better understand the mechanisms of action to help improve clinical treatments. There is also a very large lung research program at the Institute which is exploring mechanisms causing inflammatory lung disease using ex vivo lung perfusion techniques. One of the largest programs is the continual development of new ventricular assist devices and total artificial hearts. We have an outstanding large animal research lab and work in collaboration with multiple companies and the FDA perfecting the new devices for clinical testing. Researchers at the CII have published over 27 peer-reviewed articles during the year.

Operating model

Revenue model
Donor-supported. 83% of the money available for current operations came from contributions and gifts.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - The filed numbers largely add up and most voting board members are independent. A relatively small share of available resources goes toward mission work and some filing-based governance responses are negative or unanswered.

Rating breakdown

  • Financial Efficiency: 54
  • Transparency & Controls: 92
  • Accountability: 76
  • Sustainability: 43
  • Growth: 80

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 58.3%; rating input score 58
  • Program expense ratio: 65.8%; rating input score 66
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 62nd percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
  • Governance controls: 3 of 7 controls in place; rating input score 43
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: 11.4%; rating input score 70; 70th percentile among comparable filings
  • Total-asset coverage ratio: 0; rating input score 0; 0th percentile among comparable filings
  • Liabilities to assets ratio: Limited
  • Officer compensation ratio: 0%; rating input score 84; 84th percentile among comparable filings

Growth

  • Program expense growth: 18.9% per year; rating input score 100; 84th percentile among comparable filings
  • Revenue growth: 1% per year; rating input score 100; 28th percentile among comparable filings
  • Asset growth: -22.9% per year; rating input score 0; 2nd percentile among comparable filings

Details

  • What they do: 1 operating location identified
  • Where the money goes: 58.3% of revenue deployed · 65.8% of spending went to programs
  • Governance: 10 of 10 board members independent · 3 of 7 filing controls reported
  • Programs: 1 filed program accomplishment · $500K in reported program spending
  • Leadership: top reported pay $0 · 13 people listed
  • Consistency: 18 of 18 current checks pass
  • Schedules: 4 filed schedules · includes major donors
  • Filing history: 8 filing years from 2011 to 2018
  • Contacts: How to reach this organization
  • Money network: Resolved incoming and outgoing counterparties from filed money flows.
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

Grant-readiness screening is separate from the live rating, not a measure of program quality. Review the source records before making a grant decision.

  • Review — Financial Efficiency: Mission deployment rate scored 58/100.
  • Moderate — Accountability: Governance controls: 3 of 6 not reported.
  • High — Sustainability: Total-asset coverage ratio scored 0/100.
  • High — Growth: Asset growth scored 0/100.
  • High — Grant Readiness: Automatic revocation: this organization had its federal tax-exempt status automatically revoked.